Complications Related to Palatal Graft Harvesting

Sponsor
University of the Basque Country (UPV/EHU) (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06114394
Collaborator
(none)
70
1
2
27
2.6

Study Details

Study Description

Brief Summary

Soft tissue defects can be a problem, especially in patients with high smile lines; in these clinical scenarios, the treatment with periodontal plastic surgery in combination with the use of a connective tissue graft (CTG) is considered the gold-standard procedure.

Single incision technique (Huerzeler & Weng, 1999) is one of the suggested procedures to harvest the CTG from palate. The UPV/EHU technique (Aguirre-Zorzano et al, 2017) showed less inflammation and post-surgical complications than trap-door technique, but also other technique should to be analysed.

However, there is still no consensus about which is the best technique to obtain this kind of graft. Therefore, clinicians should justify their choice based on the tissue's quality obtained and the patient's well-being, producing the least number of complications, such as inflammation, post-surgical pain, or recession in the donor area.

HYPOTHESIS:

Does the technique of obtaining an CTG of the palate using the "UPV/EHU technique" (Aguirre-Zorzano et al., 2017) result in a lower number of complications versus the "single incision technique" (Huerzeler & Weng, 1999)?

OBJECTIVES The main objective is to assess whether the complications occurring with the harvesting of the CTG using the "UPV/EHU technique" (Aguirre-Zorzano et al., 2017) are lower than with the "single incision technique"(Huerzeler & Weng, 1999), knowing the patient's perception of pain.

The secondary objectives are: a) necrosis of the palate, b) possible resulting recession in the donor area, and c) characteristics of the graft obtained

Condition or Disease Intervention/Treatment Phase
  • Procedure: UPV/EHU technique (Aguirre-Zorzano et al 2017)
  • Procedure: Single incision technique (Huerzeler & Weng 1999)
N/A

Detailed Description

Type of Study: randomized clinical trial

Two different treatments (UPV/EHU technique (test) (Aguirre-Zorzano et al. 2017) vs. Single Incision technique (control) (Huerzeler & Weng, 1999)) will be compared. These techniques are usually used to harvest a CTG from the palate.

Main outcome: complications in the donor area.

Follow-up: 6 months.

UNIT OF ANALYSIS: The patient of the Master's Degree in Periodontology and Osseointegration from the University of the Basque Country (UPV/EHU), requires treatment with a CTG harvested from the palate.

SAMPLE SIZE CALCULATION: Using the visual analog pain scale (VAS pain) as the primary response variable, it is estimated that, to find a difference of 1 between test and control, with an SD= 1.26 (Wessel & Tatakis 2008), an alpha risk of 5% and a power of 85%, we would need 29 patients for each treatment group (Domenech and Granero 2010). In addition, taking into account possible dropouts, we would increase the number of patients by 20%, finally recruiting 35 patients per group.

Statistical analysis:

A descriptive study of the sample will be performed, based on moments (mean, standard deviation) if the parameters of normality are met or on ordinations (median and interquartile range), in case the parameters of normality are not met.

Subsequently, analytical statistics will be performed, and in addition, the intensity and duration of post-surgical pain after each surgical technique adjusted for possible confounding factors (clinical level of central sensitization, presence of pre-surgical pain, presence of post-surgical complications, use of added analgesic treatment) will be assessed using logistic regression.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
70 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
We will perform the experimental or control technique according to the randomization sequence.We will perform the experimental or control technique according to the randomization sequence.
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Masking Description:
Participant: Initially, the subject will not know what technique has been received, the complete information regarding the surgical technique used, as the results obtained in his case, will be given in the last visit of the year. Observer: Another periodoncist (R.E.), outside the intervention, would be in charge of recording the clinical parameters. Analyst: The statistician (X.M.) does not know which treatment corresponds to each variable.
Primary Purpose:
Treatment
Official Title:
Analysis of the Complications in Palatal Graft Harvesting With the UPV/EHU Technique vs. Single Incision Technique.
Anticipated Study Start Date :
Oct 30, 2023
Anticipated Primary Completion Date :
Dec 30, 2025
Anticipated Study Completion Date :
Jan 30, 2026

Arms and Interventions

Arm Intervention/Treatment
Experimental: UPV/EHU technique (Aguirre-Zorzano et al 2017)

Harvesting a connective tissue graft from palate by the UPV/EHU technique.

Procedure: UPV/EHU technique (Aguirre-Zorzano et al 2017)
The "UPV/EHU technique" (Aguirre-Zorzano et al., 2017) begins with the elevation of the full thickness flap (FTF) in the palate and an intrasulcular incision performed with a number 12 blade, preserving the papillae in the interproximal spaces. Then, the FTF is dissected with a 15c blade, holding the flap with tissue forceps, leaving the epithelium and a thin layer of the connective tissue in the flap, so that the underlying connective tissue can be harvested. After that the flap is sutured.

Active Comparator: Single incision technique (Huerzeler & Weng 1999)

Harvesting a connective tissue graft from palate by the single incision technique

Procedure: Single incision technique (Huerzeler & Weng 1999)
The CTG is harvested with the single incsion technique described by Huerzeler & Weng in 1999.

Outcome Measures

Primary Outcome Measures

  1. Post-surgical pain perception [After surgery up to 14 days]

    The subject will we instructed to collect their perception of post-surgical pain in the VAS based on the UPV/EHU Pain diary (Fernandez-Jimenez et al, 2021). Specifically the subject will record: Its intensity (0-100mm), its duration (minutes or hours) and if any analgesic treatment has been necessary (No o Yes: Which?).

Secondary Outcome Measures

  1. Central Sensitization Inventory severity-level score of the subject Central Sensitization inventory (CSI) (Mayer et al. 2012) [Baseline]

    Central Sensitization inventory (CSI) (Mayer et al. 2012) will be done, in which each subject will be asked on the frequency in which he perceives 25 symptoms and will be given a score of 0-4 finally establishing a clinical level in a range of 0-100 points (Subclinical: 0-29; Medium: 30-39; Moderate: 40-49 ; Severe: 50-59; Extreme: 60-100).

  2. Pre-surgical pain perception. [Baseline]

    In the VAS based on the UPV/EHU Pain Diary (Fernandez-Jimenez et al 2021) the examiner will record if the subject has had regional head and neck pain in the last month and if there is any pain in the immediate preoperative, if it is affirmative the intensity will be noted

  3. Necrosis of the palate [up to 7 days post-srugery]

    After using 2 CP-11 periodontal probes by placing them perpendicularly, thus obtaining a measured in the X-axis and another in the Y-axis and multiplying both results, the donor area in mm2 will be obtained. From that point on, it will be possible to determine what degree of necrosis has occurred in the donor area by taking the following values as a reference (Aguirre-Zorzano et al. 2017): Value 0: total absence of necrosis. Value 1 : ≦30% of the donor area. Value 2: ≧ 30% of the donor area.

  4. Gingival recession (REC) in donor area [Change from baseline at following surgery sixth month respectively.]

    Distance in mm from the amelocementaria line the gingival margin, measured at the vestibular midpoint. It will be registered in all the teeth present in the donor area at the beginning, and, during the follow-up only in the recessions to be treated

  5. Post-surgical complications [After surgery first seven days.]

    The presence or not, as the description, of the post-surgical complications (PSC) that may appear will be collected.

  6. Thickness of the donor area of the palate and of the connective tissue graft [Surgery]

    measured using 2 CP-11 periodontal probes and placing them perpendicularly, thus creating a measurement in the X axis and another in the Y axis, in order to obtain the area in mm2 of the graft obtained by multiplying both measurements, and placing a file with a rubber stopper in the central area of the graft to measure its thickness.

  7. Length of the donor area of the palate and of the obtained CTG(mm) [Surgery]

    by positioning a CP-11 periodontal probe parallel to the donor area on the palate, as well as on the connective tissue graft obtained

  8. Width of the donor area of the palate and of the obtained CTG (mm) [Surgery]

    by positioning a CP-11 periodontal probe perpendicular to the donor area on the palate, as well as on the obtained connective tissue graft.

  9. Area (mm2) of the donor area of the palate and of the obtained CTG [Surgery]

    : measurement obtained by multiplying the variables length and width of the donor area, as well as of the obtained CTG.

  10. Extension of the bed recipient. [Baseline]

    The number of teeth or implants will be registered in the bed receipt.

  11. Full mouth bleeding index (FMBI) (Aynamo & Bay, 1975) [Change from baseline at following surgery sixth month respectively.]

    After a periodontal probing of all teeth, the presence (yes or no) of bleeding is recorded dichotomously at 6 points per tooth (mesio-bucal, mid-bucal, disto-bucal, mesio-lingual, mid-lingual and disto-lingual) and the percentage of sites that bleed from the total of probed sites is calculated (Ainamo and Bay 1975)

  12. Full mouth plaque index (FMPI). [Change from baseline at following surgery sixth month respectively.]

    A plaque developer is used and the presence (yes or no) of plaque is recorded dichotomously at 6 points per tooth (mesio-bucal, mid-bucal, disto-bucal, mesio-lingual, mid-lingual and disto-lingual) and the percentage of sites with plaque of the total probed sites is calculated (O'Leary et al 1972).

  13. Probing depth (PD) [Change from baseline at following surgery sixth month respectively.]

    Distance in millimeters from the gingival margin to the bottom of the periodontal pocket. It will be recorded at the beginning in all teeth present (except wisdow teeth) in 6 points per tooth (mesio-bucal, mid-bucal, disto-bucal, mesio-lingual, mid-lingual and disto-lingual) and, during follow-up, only in the recessions to be treated at the vestibular mid-point.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Patients of the UPV/EHU university dental clinic who required a connective graft of the palate in their treatment.

  • Patients ≥ 18 years-old

  • Absence of active periodontal disease ( healthy periodontal patients or periodontal patients who had received active periodontal treatment, and now they are included in a tailored supportive periodontal program)

  • Full-mouth plaque index (FMPI) (O'Leary y cols. 1972) and full-mouth bleeding index (FMBI) (Ainamo y Bay, 1975) ≤ 25%

Exclusion Criteria:
  • Smokers of ≥ 10 cigarettes/day

  • Systemic conditions that contraindicated surgery

  • The use of analgesic and/or anti-inflammatory drugs in the last 72 h

  • The use of opioid drugs, anticonvulsants and/or antidepressants, except selective serotonin inhibitors, i.e., those drugs that act by reducing the painful experience

  • Pregnancy or nursing women

Contacts and Locations

Locations

Site City State Country Postal Code
1 UPV/EHU Leioa Vizcaya Spain 48940

Sponsors and Collaborators

  • University of the Basque Country (UPV/EHU)

Investigators

  • Study Director: ANA MARIA GARCIA DE LA FUENTE, PHD, UPV/EHU

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Ana María García de la Fuente, Professor, University of the Basque Country (UPV/EHU)
ClinicalTrials.gov Identifier:
NCT06114394
Other Study ID Numbers:
  • 2023_01
First Posted:
Nov 2, 2023
Last Update Posted:
Nov 3, 2023
Last Verified:
Nov 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Ana María García de la Fuente, Professor, University of the Basque Country (UPV/EHU)
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 3, 2023